A modified method for determination of lumefantrine in human plasma by HPLC-UV and combination of protein precipitation and solid-phase extraction: Application to a pharmacokinetic study

Analytical Chemistry Insights

Volumn 2010, Issue 5, 2010, Pages 15-23

  Huang, Liusheng ^a   Lizak, Patricia S ^a   Jayewardene, Anura L ^a   Marzan, Florence ^a   Lee, Ming Na Tina ^a   Aweeka, Francesca T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Halofantrine; HPLC UV; Lumefantrine; Protein precipitation; SPE

Indexed keywords

EID: 77951940101     PISSN: None     EISSN: 11773901     Source Type: Journal    
DOI: 10.4137/aci.s4431     Document Type: Article

References (9)

1. Guinovart C, Navia MM, Tanner M, Alonso PL, Curr Mol Med. 2006; 6:137.
2. World Health Organization, Practical Chemotherapy of Malaria, W.H.O Technical Report Series No. 805. Geneva. 1990.
3. Colussi D, Parisot C, Legay F, Lefevre G. Eur J Pharm Sci. 1999;9:9-16.
4. Blessborn D, Romsing S, Annerberg A, et al. Pharm Biomed Analys. 2007;45:282-7.
5. Mansor SM, Navaratnam V, Yahaya N, Nair NK, Wernsdorfer WH, Degen PH, J. Chromatogr B. 1996;682:321-5.
6. Lindegardh N, Annerberg A, Blessborn D, Bergqvist Y, Day N, White NJ, J Pharm Biomed Analys. 2005;37:1081-8.
7. ACTG guidelines for method development and validation based on (and including) FDA guidelines dated by 2001. Version 2, 2005.
8. Boyd RK, Rapid Commun Mass Sp. 1993;7:257-71.
9. Zeng M, Lu Z, Yang S, et al. J Chromatogr B. 1996;681:299-306.